Changes in cerebral connectivity and brain tissue pulsations with the antidepressant response to an equimolar mixture of oxygen and nitrous oxide: an MRI and ultrasound study.
Thomas Desmidt, Paul-Armand Dujardin, Frédéric Andersson, Bruno Brizard, Jean-Pierre Réméniéras, Valérie Gissot, Nicolas Arlicot, Laurent Barantin, Fabien Espitalier, Catherine Belzung, Arnaud Tanti, Gabriel Robert, Samuel Bulteau, Quentin Gallet, François Kazour, Sandrine Cognet, Vincent Camus, Wissam El-Hage, Pierre Poupin, Helmet T Karim
Molecular Psychiatry September 1, 2023 DOI: 10.1038/s41380-023-02217-6 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Sample size | 30 |
| Population | Women aged 25-50 with treatment-resistant major depressive episode or healthy controls |
| Intervention | Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) |
| Duration | 1-hour exposure, 1-week follow-up |
| Measures | MADRS, resting state fMRI, Tissue Pulsatility Imaging |
| Key findings | A single session of EMONO rapidly modifies functional connectivity in the subgenual ACC-precuneus and increases brain tissue pulsations, with larger early pulsation increases associated with antidepressant response. |
Abstract
Nitrous oxide (N2O) has recently emerged as a potential fast-acting antidepressant but the cerebral mechanisms involved in this effect remain speculative. We hypothesized that the antidepressant response to an Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) would be associated with changes in cerebral connectivity and brain tissue pulsations (BTP). Thirty participants (20 with a major depressive episode resistant to at least one antidepressant and 10 healthy controls-HC, aged 25-50, only females) were exposed to a 1-h single session of EMONO and followed for 1 week. We defined response as a reduction of at least 50% in the MADRS score 1 week after exposure. Cerebral connectivity of the Anterior Cingulate Cortex (ACC), using ROI-based resting state fMRI, and BTP, using ultrasound Tissue Pulsatility Imaging, were compared before and rapidly after exposure (as well as during exposure for BTP) among HC, non-responders and responders. We conducted analyses to compare group × time, group, and time effects. Nine (45%) depressed participants were considered responders and eleven (55%) non-responders. In responders, we observed a significant reduction in the connectivity of the subgenual ACC with the precuneus. Connectivity of the supracallosal ACC with the mid-cingulate also significantly decreased after exposure in HC and in non-responders. BTP significantly increased in the three groups between baseline and gas exposure, but the increase in BTP within the first 10 min was only significant in responders. We found that a single session of EMONO can rapidly modify the functional connectivity in the subgenual ACC-precuneus, nodes within the default mode network, in depressed participants responders to EMONO. In addition, larger increases in BTP, associated with a significant rise in cerebral blood flow, appear to promote the antidepressant response, possibly by facilitating optimal drug delivery to the brain. Our study identified potential cerebral mechanisms related to the antidepressant response of N2O, as well as potential markers for treatment response with this fast-acting antidepressant.
Citations in the library
Cited by 7
- Anesthetics as Treatments for Depression: Clinical Insights and Underlying Mechanisms. Annual Review of Neuroscience February 19, 2025
- Rapid antidepressant potential of nitrous oxide: current state and major questions. Molecular Psychiatry June 1, 2026
- Sustained mood improvement with laughing gas exposure (SMILE): a randomised, placebo-controlled pilot trial of nitrous oxide for treatment-resistant depression: commentary, Kalmar et al BJPsych Open July 1, 2026
- Nitrous oxide for late-life depression with inadequate antidepressant response: a randomised controlled trial. EClinicalMedicine April 2, 2026
- Nitrous oxide for the treatment of depression: a systematic review and meta-analysis. EBioMedicine December 1, 2025
and 2 more in the library
Cites 11
- The anterior cingulate cortex as a key locus of ketamine’s antidepressant action Neuroscience & Biobehavioral Reviews May 10, 2021
- Nitrous oxide as an adjunctive therapy in major depressive disorder: a randomized controlled double-blind pilot trial Brazilian Journal of Psychiatry February 18, 2021
- Intrinsic Connectivity Networks of Glutamate-Mediated Antidepressant Response: A Neuroimaging Review Frontiers in Psychiatry May 26, 2022
- Proof-of-concept randomized controlled trial of single-session nitrous oxide treatment for refractory bipolar depression: Focus on cerebrovascular target engagement. Bipolar Disorders May 1, 2023
- Efficacy and safety of nitrous oxide for patients with treatment-resistant depression, a randomized controlled trial. Psychiatry Research November 1, 2022
and 6 more in the library